Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxia Su

Showing results (111-120 of 223) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|May 17, 2022
Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in ChinaChunxia Su, Juan Zhou, Huiping Qiang, et al.
Frontiers in Public Health|May 22, 2023
Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?Yu Xia, Yingyao Chen, Jia Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2019
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastasesTao Jiang, Yongchang Zhang, Xuefei Li, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2021
Epidermal growth factor receptor tyrosine kinase inhibitor remodels tumor microenvironment by upregulating LAG-3 in advanced non-small-cell lung cancerJuan Zhou, Xin Yu, Likun Hou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Long-term aspirin intervention can inhibit TIGIT, regulating T cells to reverse damage to intestinesXiaojuan Yang, Jinghua Tian, Bin Ma, et al.
RSC Advances|May 11, 2022
Effect of sodium alginate on the stability of natural soybean oil body emulsionsChunxia Su, Younan Feng, Jing Ye, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2020
HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transitionQi Wang, Xuefei Li, Shengxiang Ren, et al.
Translational Lung Cancer Research|September 21, 2020
The impact of <i>EGFR</i> exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancerChao Zhao, Tao Jiang, Jiayu Li, et al.
International Journal of Biological Macromolecules|August 6, 2025
Tumor-derived exosome-based microRNA-206 delivery system as dual modulators of the immune microenvironment and gut microbiota for colorectal cancer therapyJinhua Tian, Miao Liu, Xiaojuan Yang, et al.
Translational Lung Cancer Research|May 9, 2022
The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastasesJuan Zhou, Yinfei Wu, Mengqing Xie, et al.
Pageof 23

Showing results (111-120 of 223) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|May 17, 2022
Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in ChinaChunxia Su, Juan Zhou, Huiping Qiang, et al.
Frontiers in Public Health|May 22, 2023
Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?Yu Xia, Yingyao Chen, Jia Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2019
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastasesTao Jiang, Yongchang Zhang, Xuefei Li, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2021
Epidermal growth factor receptor tyrosine kinase inhibitor remodels tumor microenvironment by upregulating LAG-3 in advanced non-small-cell lung cancerJuan Zhou, Xin Yu, Likun Hou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Long-term aspirin intervention can inhibit TIGIT, regulating T cells to reverse damage to intestinesXiaojuan Yang, Jinghua Tian, Bin Ma, et al.
RSC Advances|May 11, 2022
Effect of sodium alginate on the stability of natural soybean oil body emulsionsChunxia Su, Younan Feng, Jing Ye, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2020
HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transitionQi Wang, Xuefei Li, Shengxiang Ren, et al.
Translational Lung Cancer Research|September 21, 2020
The impact of <i>EGFR</i> exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancerChao Zhao, Tao Jiang, Jiayu Li, et al.
International Journal of Biological Macromolecules|August 6, 2025
Tumor-derived exosome-based microRNA-206 delivery system as dual modulators of the immune microenvironment and gut microbiota for colorectal cancer therapyJinhua Tian, Miao Liu, Xiaojuan Yang, et al.
Translational Lung Cancer Research|May 9, 2022
The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastasesJuan Zhou, Yinfei Wu, Mengqing Xie, et al.
Pageof 23